Company intelligence / Profile preview
Hankook Shinyak
Nonsan, Chungcheongnam-do, South Koreahsp.co.kr ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hankook Shinyak manufactures more than 300 traditional herbal-based drugs, cosmetic products with botanical extracts, and achieved recognition for developing TAXOL (generic paclitaxel, an anti-cancer drug)[4][3]. MESIMA EX (Phellinus linteus mycelium extract) is marketed as an immunostimulant. No ongoing clinical trial data found; primarily commercial-stage herbal and natural products.
- Therapeutic areas
- ImmunologyOncology
- Modalities
- Traditional herbal extract drugsSmall moleculeNatural product extractBiologic
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
HERB OF EDEN CO. (Washington D.C.; export partner)MESIMA EX sales partnership (partly with DEXCO Trading Inc. as supplier)
Beyond the preview
Go deeper on Hankook Shinyak.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hankook Shinyak.